This event is now apart of the Clinical Diagnostics & Research Virtual Event Series.
Labroots' 1st Annual Event in the Precision Medicine Virtual Event Series 2016 is now On Demand. Watch a remarkable line-up of industry, government and academic experts, including architects of the Precision Medicine Initiative, in recorded webcasts any time. These presentations showcase the latest advances in diagnostics, therapeutics and individualized medicine that are transforming the future of personalized healthcare.
Learn more about this exciting event by watching this video.
Imagine receiving a full diagnosis from a simple blood test, or the ability to tailor the perfect treatment to your individual genetic makeup, taking into account your specific susceptibilities to side effects. What if we could apply a patient’s genetic information to gain insights into the genetic variations of diseases and expedite drug development, to create more precise therapies? This is the goal of Precision Medicine.
Precision Medicine Initiative ® (PMI) is a Presidential initiative, calling for initial funding of $215 million to support the creation of a national research cohort of 1 million or more U.S. volunteers (the PMI Cohort Program; $130 million), new efforts in cancer drug development ($70 million), advances in FDA regulatory structures ($10 million), and development of interoperability standards and requirements that address privacy and enable secure exchange of data across systems through the ONC ($5 million). The PMI builds on stunning advances in next-generation sequencing, genome biology, cancer diagnostics, biomarkers, targeted drug development, adaptive clinical trials, and digital health.
Since the completion of the Human Genome Project, extraordinary progress has been made in understanding the reach and impacts of human genetic variation. Advances in sequencing, genomic analysis, biomarker detection, coupled with new insights into rational drug design and repurposing, have given doctors more powerful and selective tools to help treat disease by tailoring medicines to an individual's genetic profile. Given that individuals’ health and disease are woven into a complex web of factors, the PMI Research Cohort will assemble not only genetic, but also environmental, behavioral, and clinical data so that researchers may understand the full range of factors that inform health and disease as they search for precision approaches to health maintenance, disease prevention, and therapies.
We are proud to include C&EN as our partner in this virtual event.
“Doctors have always recognized that every patient is unique, and doctors have always tried to tailor their treatments as best they can to individuals. You can match a blood transfusion to a blood type — that was an important discovery. What if matching a cancer cure to our genetic code was just as easy, just as standard? What if figuring out the right dose of medicine was as simple as taking our temperature?”
--- President Obama, January 30, 2015
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
Use #LRprecisionmed to follow the conversation
Jean C. and James W. Crystal Professor of Genomics, Chairman and Professor, Department of Genetics and Genomic Sciences, Director, Icahn Institute for Genomics and Multiscale Biology, Icahn S
Associate Professor of Medicine (Cardiovascular), of Genetics and, by courtesy, of Pathology at the Stanford University Medical Center
Professor of Bioinformatics, Head of Department of Medical & Molecular Genetics, Director of Bioinformatics King's Health Partners, Faculty of Life Sciences & Medicine, King's College London
Professor, Computer Science and AI Lab, Director, MIT Computational Biology Group, Broad Institute of MIT and Harvard
Director of the Innovation Center for Biomedical Informatics (ICBI) and Associate Professor of Oncology, Georgetown University Medical Center
Research Professor Division of Chemical Systems & Synthetic Biology Department of Integrative Biomedical Sciences, University of Cape Town Faculty of Health Sciences
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease and the development of molecular, cell and gene therapies to enable ...See more See less
Helmer Scientific is an established, entrepreneurial, growth company headquartered in Noblesville, Indiana. We design, integrate, manufacture, market, and distribute specialized medical and laboratory equipment to clinical and life science customers in over 125 countries.
Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell ...See more See less
SomaLogic® was founded in 2000 by Larry Gold, with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. Building on the previous decade of aptamer research, SomaLogic scientists have developed a ...See more See less
Labroots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities.
Chemical & Engineering News is a weekly magazine published by the American Chemical Society. C&EN editors and reporters based in Europe, the U.S., and Asia cover science and technology, business and industry, government and policy, education, and employment aspects of the ...See more See less
The ADDF is committed to investing in a diverse portfolio of research programs and strengthening our network of partnerships until we discover a cure. The ADDF focuses its funding entirely on preclinical research and early-stage clinical trials involving new drug targets that ...See more See less
Biocompare (www.biocompare.com) is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer ...See more See less
Founded in 1912, the Federation of American Societies for Experimental Biology (FASEB) was originally created by three independent scientific organizations to provide a forum in which to hold educational meetings, develop publications, and disseminate biological research results ...See more See less
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular ...See more See less
Globetech Media is a world leader in international controlled-circulation media serving biomedical and other high-tech sectors. Globetech magazines serve over 500,000 readers in more than 180 countries around the world. Globetech online media serve extensive vertical communities ...See more See less
Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...See more See less
PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE's ...See more See less
Pittcon is the worlds largest annual premier conference and exposition on laboratory science. It is organized by The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania not-for-profit educational corporation which is comprised of the ...See more See less
Founded in 2004, Research Square provides innovative solutions to help researchers successfully communicate their work. These solutions include author and manuscript services from AJE American Journal Experts as well publisher solutions such as peer review, independent ...See more See less
Kevin Davies, Ph.D. is an author, editor and publisher with 25 years' experience in the world of scientific publishing. He is currently publisher of C&EN (Chemical & Engineering News), the weekly news and science magazine of the American Chemical Society, the largest scientific ...See more See less